Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets
2021 · Nature Communications · 122 citations
https://doi.org/10.1038/s41467-021-26760-4
R
Robert M. Cox
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
95
Papers
2.8K
Citations
25
h-index
49
i10-index
Robert M. Cox is an academic researcher from Georgia State University. The author has contributed to research in topics: Respiratory viral infections research & Virology and Viral Diseases & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 25, co-authored 81 publications.
ORCID: 0000-0003-0620-1674Papers by this author
worksSARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model
2022 · Nature Communications · 49 citations
https://doi.org/10.1038/s41467-022-32045-1
Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models
2023 · Nature Communications · 32 citations
https://doi.org/10.1038/s41467-023-40556-8
The small molecule inhibitor of SARS-CoV-2 3CLpro EDP-235 prevents viral replication and transmission in vivo
2024 · Nature Communications · 25 citations
https://doi.org/10.1038/s41467-024-50931-8
Zoonotic potential of a novel bat morbillivirus
2021 · Research Square · 14 citations
https://doi.org/10.21203/rs.3.rs-926789/v1
Therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections in ferrets
2024 · Nature Communications · 8 citations
https://doi.org/10.1038/s41467-024-45418-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat